HomeInsightsPE

Supriya Lifescience Ltd PE Ratio

Supriya Lifescience Ltd PE Ratio

stocks purchased

₹ 0.7 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

9.9 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 11, 2024

Image

Supriya Lifescience Ltd

NSE: SUPRIYA

PE

39.4

Last updated on: Dec 11, 2024

Key Highlights

  • The P/E Ratio of Supriya Lifescience Ltd is 39.4 as of 11 Dec 12:55 PM .
  • The P/E Ratio of Supriya Lifescience Ltd changed from 26.1 on March 2022 to 22.4 on March 2024 . This represents a CAGR of -4.97% over 3 years.
  • The Latest Trading Price of Supriya Lifescience Ltd is ₹ 757 as of 11 Dec 12:50 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Supriya Lifescience Ltd

No data available

Company Fundamentals for Supriya Lifescience Ltd

No data available

Image

Supriya Lifescience Ltd

NSE: SUPRIYA

Share Price

₹ 757

-13.30 (-1.73%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Supriya Lifescience Ltd

1M

1Y

3Y

5Y

Monitoring Supriya Lifescience Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Dec 2024770.3
09 Dec 2024784.45
06 Dec 2024774.15
05 Dec 2024778.05
04 Dec 2024804.3
03 Dec 2024795.8
02 Dec 2024778.6
29 Nov 2024776.45
28 Nov 2024757.85
27 Nov 2024787.45

SWOT Analysis Of Supriya Lifescience Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Supriya Lifescience Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Supriya Lifescience Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Supriya Lifescience Ltd396,199
Sun Pharmaceuticals Industries Ltd384,34,148
Divis Laboratories Ltd851,57,464
Cipla Ltd251,17,560
Torrent Pharmaceuticals Ltd651,13,318
Mankind Pharma Ltd501,06,927

Key Valuation Metric of Supriya Lifescience Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Supriya Lifescience Ltd

No data available

* All values are in crore

Historical Revenue of Supriya Lifescience Ltd

No data available

* All values are in crore

Historical EBITDA of Supriya Lifescience Ltd

No data available

* All values are in crore

Historical Net Profit of Supriya Lifescience Ltd

No data available

* All values are in crore

Historical Dividend Payout of Supriya Lifescience Ltd

No data available

* All values are in %

About Supriya Lifescience Ltd

  • Supriya Lifescience Limited was initially constituted on October 29, 1985, as a 'Partnership Firm under the name M/s Supriya Chemicals'.
  • The Partnership Firm was last re-constituted pursuant to a Partnership Deed dated November 30, 2007.
  • Upon the conversion of M/s Supriya Chemicals' the Partnership Firm into a Public Limited Company, the Company got incorporated as Supriya Lifescience Limited' vide certified on March 26, 2008 by the Registrar of Companies, Mumbai. The Company commenced operations in April, 2008.
  • It is engaged in manufacturing and export of active pharmaceutical ingredients (APIs).
  • The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development.

Supriya Lifescience Ltd News Hub

News

Supriya Lifescience standalone net profit rises 56.58% in the June 2024 quarter

Net profit of Supriya Lifescience rose 56.58% to Rs 44.64 crore in the quarter ended June ...

Read more

2024-08-12 00:00:00

News

Supriya Lifesciences to convene board meeting

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 10 Au...

Read more

2024-08-06 00:00:00

News

Supriya Lifesciences to hold AGM

Supriya Lifesciences announced that the Annual General Meeting (AGM) of the company will b...

Read more

2024-09-14 00:00:00

News

Supriya Lifesciences to announce Quarterly Result

Supriya Lifesciences will hold a meeting of the Board of Directors of the Company on 28 Oc...

Read more

2024-10-21 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Supriya Lifescience Ltd

What is the current PE Ratio of Supriya Lifescience Ltd?

The Current PE Ratio of Supriya Lifescience Ltd is 39.36 as on 11 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Dec 2024.

What was the PE Ratio of Supriya Lifescience Ltd last year?

The PE Ratio of Supriya Lifescience Ltd was 17.09 last year, now the PE ratio is 39.36, showing a year-on-year growth of 130.3%.

What does the PE Ratio of Supriya Lifescience Ltd indicate about its stock?

The PE Ratio of Supriya Lifescience Ltd is 39.36. This ratio indicates that investors are willing to pay 39.36 times the earnings per share for each share of Supriya Lifescience Ltd.

What is the PE Ratio Growth of Supriya Lifescience Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Supriya Lifescience Ltd grew by 130.3% whereas, the EPS ratio grew by 3.1.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions